Budweiser to be buddy for Lipitor

The Lipitor Scorecard is a popular feature of IP scholar and strategist Duncan Bucknell's website. It charts the state of progress - and eventually the result - of the disputes between Ranbaxy and Pfizer over the Lipitor patent in 16 separate jurisdictions. Well, now that Duncan has established the concept, he's looking for a bigger challenge. Having learned from the IPKat that Anheuser-Busch and Budejovicky Budwar have been slugging it out in some 40 countries for the right to control the use of the talismanic word BUDWEISER, he'd like to compose a Budweiser Scorecard too.

To this end, the IPKat - who does not have a complete list himself but who does have a readership from around the world - asks readers to contact Duncan with details of the Budweiser battle(s) that have taken place in their own jurisdictions. Please email Duncan here if you can help, and tell him the IPKat sent you. Then, once Duncan has done all the hard work, we can sit back and read it ...
Budweiser to be buddy for Lipitor Budweiser to be buddy for Lipitor Reviewed by Jeremy on Wednesday, April 11, 2007 Rating: 5

1 comment:

  1. It's fun, but I'm afraid I wouldn't describe it as a scorecard. In fact, Sir, under the State Law of Illinois I put it to you that you've "tortuously interfered with my business expectancy" to describe it as such.

    What's the score, Duncan ? Is it 7-1; 120 all out; 68-64; 6 love, 6 love, 6 love; don't tell us we have to work it out for ourselves.

    He may find the Budweiser task a little harder since most of their disputes end in 'score draws' don't they ?


All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.